Kevin M. King's most recent trade in Inogen Inc was a trade of 30,612 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 30,612 | 76,885 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 21,871 | 46,273 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,094 | 24,402 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 6,849 | 7,308 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 459 | 459 (0%) | 0% | 0 | Common Stock | |
| iRhythm Technologies Inc | Kevin M. King | Director | Sale of securities on an exchange or to another person at price $ 132.67 per share. | 04 Mar 2022 | 6,815 | 250,422 (0%) | 0% | 132.7 | 904,160 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 951 | 257,237 (0%) | 0% | 0 | Common Stock | |
| iRhythm Technologies Inc | Kevin M. King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2021 | 2,836 | 85,372 | - | - | Employee Stock Option (right to buy) | |
| iRhythm Technologies Inc | Kevin M. King | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.25 per share. | 08 Apr 2021 | 2,836 | 256,286 (0%) | 0% | 35.3 | 99,969 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 152.92 per share. | 01 Mar 2021 | 11,890 | 253,450 (0%) | 0% | 152.9 | 1,818,219 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2021 | 37,530 | 283,948 (1%) | 0% | 0 | Common Stock | |
| iRhythm Technologies Inc | Kevin M. King | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.57 per share. | 17 Jan 2021 | 18,608 | 265,340 (0%) | 0% | 250.6 | 4,662,607 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 233.05 per share. | 12 Jan 2021 | 2,928 | 246,360 (0%) | 0% | 233.0 | 682,370 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 12 Nov 2020 | 17,918 | 260,019 (0%) | 0% | 17 | 304,606 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 17,918 | 0 | - | - | Employee Stock Option (right to buy) | |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.25 per share. | 12 Nov 2020 | 11,792 | 273,770 (1%) | 0% | 35.3 | 415,668 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 11,792 | 88,208 | - | - | Employee Stock Option (right to buy) | |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 255.19 per share. | 12 Nov 2020 | 9,724 | 254,602 (0%) | 0% | 255.2 | 2,481,502 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 256.16 per share. | 12 Nov 2020 | 9,659 | 244,943 (0%) | 0% | 256.2 | 2,474,277 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 254.41 per share. | 12 Nov 2020 | 5,438 | 264,326 (0%) | 0% | 254.4 | 1,383,478 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 251.86 per share. | 12 Nov 2020 | 2,210 | 271,560 (1%) | 0% | 251.9 | 556,619 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 258.26 per share. | 12 Nov 2020 | 2,152 | 242,101 (0%) | 0% | 258.3 | 555,776 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.18 per share. | 12 Nov 2020 | 1,959 | 261,978 (0%) | 0% | 8.2 | 16,025 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 1,959 | 0 | - | - | Employee Stock Option (right to buy) | |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 252.43 per share. | 12 Nov 2020 | 1,796 | 269,764 (1%) | 0% | 252.4 | 453,362 | Common Stock |
| iRhythm Technologies Inc | Kevin M. King | President and CEO | Sale of securities on an exchange or to another person at price $ 257.25 per share. | 12 Nov 2020 | 690 | 244,253 (0%) | 0% | 257.3 | 177,504 | Common Stock |